Stayble Therapeutics AB (publ) (FRA:4K4)
0.0210
+0.0008 (3.96%)
At close: Jan 5, 2026
Stayble Therapeutics AB Statistics
Total Valuation
FRA:4K4 has a market cap or net worth of EUR 1.46 million. The enterprise value is 1.19 million.
| Market Cap | 1.46M |
| Enterprise Value | 1.19M |
Important Dates
The next estimated earnings date is Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 64.36M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +54.55% |
| Shares Change (QoQ) | +41.48% |
| Owned by Insiders (%) | 4.13% |
| Owned by Institutions (%) | 13.27% |
| Float | 56.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.91 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.56 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.19, with a Debt / Equity ratio of 0.10.
| Current Ratio | 7.19 |
| Quick Ratio | 6.74 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -180.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -92.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -380,648 |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -52.05% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 47.26 |
| Average Volume (20 Days) | 66 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -781,381 |
| Pretax Income | -761,296 |
| Net Income | -761,296 |
| EBITDA | n/a |
| EBIT | -781,381 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 343,984 in cash and 76,883 in debt, with a net cash position of 267,101.
| Cash & Cash Equivalents | 343,984 |
| Total Debt | 76,883 |
| Net Cash | 267,101 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 764,852 |
| Book Value Per Share | 0.01 |
| Working Capital | 330,779 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:4K4 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.55% |
| Shareholder Yield | -54.55% |
| Earnings Yield | -52.06% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |